Find News

Filter articles

Showing 11 to 20 of 2458 results

China, Canada and US labs collaborate over neurological disorder therapies

Canada, China, US10-04-2019

Chinese companies have entered into a research agreement with scientists in the US and Canada to develop a therapy for neurological disorders by using the natural power of the immune system.

FTC approves Fresenius’s $2bn acquisition of NxStage Medical


The US Federal Trade Commission has issued a final approval of Fresenius Medical Care’s $2 billion acquisition of medical device company NxStage Medical.

Duane Morris hires Winston & Strawn lawyer

Taiwan, US10-04-2019

Duane Morris & Selvam has strengthened its IP practice with the addition of John Alison from Winston & Strawn.

Athena asks for rehearing on invalidated neurological disorder patent


Athena Diagnostics has asked the US Federal Circuit to revisit its decision earlier this year, which found four claims in one of its patents to be invalid.

Alnylam and Regeneron unveil RNAi partnership


Pharmaceutical companies Alnylam and Regeneron will collaborate on the development and commercialisation of RNA interference therapeutics.

Sun Pharma takes Pfizer to court over Lyrica


India-based drugmaker Sun Pharma has accused Pfizer of infringing a patent with a new extended-release formulation of Lyrica.

FDA boosts customs collaboration to fight fake drugs


The US Food and Drug Administration and US Customs and Border Protection have strengthened their collaboration in a bid to halt the import of counterfeit drugs and protect public health.

Abbvie faces multiple Humira antitrust suits


AbbVie is now facing six antitrust class-action lawsuits which claim that the company illegally stopped competition for its arthritis treatment Humira.

EU court rejects Medrobotics TM appeal


Massachusetts-based Medrobotics has failed to convince the EU General Court that its trademark for ‘See More. Reach More. Treat More.’ should be registered.

EPO grants eukaryotic cell CRISPR patent to Charpentier


The European Patent Office has issued a new CRISPR/Cas9 patent to inventor Emmanuelle Charpentier, one of the key figures in the CRISPR landscape.

Showing 11 to 20 of 2458 results